The U.S. Army is approaching a major benchmark in its effort to strengthen brain-health monitoring across the force, with about 97% of soldiers having used the Neurocognitive Assessment Tool, according to the service's top leader overseeing safety and occupational health.
The figure suggests the Army has moved well beyond pilot-stage adoption and into broad operational use of a screening system designed to help medical professionals identify the effects of blast overpressure and repeated low-level blast exposure. Those exposures, long associated with combat arms, training ranges and explosives handling, have become a growing concern for military medicine as researchers and commanders better understand their cumulative impact on cognition, balance, reaction time and long-term neurological health.
Broad Adoption Reached
The near-universal use of the tool is significant not only because of the scale, but because of what it represents in military health policy: a shift toward routine monitoring rather than waiting for symptoms to become severe enough to trigger treatment. In practice, that means the Army is increasingly trying to build a baseline picture of a soldier's cognitive health and then compare future results against it, giving clinicians a better chance of spotting subtle changes that may otherwise be missed.
That approach matters in a force where exposure can occur in both combat and training. Blast overpressure is not limited to direct battlefield incidents; it can also arise from repeated firing of heavy weapons, breaching operations, artillery practice and other routine activities. Low-level blast exposure, while less dramatic than a single major event, is now widely viewed as a cumulative risk that may affect service members over time. The Army's emphasis on the Neurocognitive Assessment Tool indicates that leadership is treating the issue as an occupational health challenge, not merely a battlefield injury.
The 97% adoption rate also reflects the Army's ability to push medical screening tools across a large and dispersed organization. That kind of uptake generally requires command support, training, integration into medical workflows and a clear explanation to soldiers about why the testing matters. In a military environment, where time is limited and operational demands are high, widespread compliance can be difficult to achieve unless the tool is seen as practical and credible.
Blast Risk Under Scrutiny
The Army's focus comes amid broader concern across the U.S. military and allied forces about the neurological consequences of repeated exposure to blast events. While severe traumatic brain injury has long been recognized, the more difficult question has been how to detect and manage the effects of smaller, repeated exposures that may not produce immediate symptoms but could still degrade performance or contribute to longer-term harm.
That challenge has pushed military medicine toward more sophisticated screening, data collection and follow-up care. The Neurocognitive Assessment Tool is part of that effort, giving medical professionals a standardized way to evaluate soldiers and track changes over time. For commanders, the value lies in preserving readiness; for clinicians, it lies in identifying risk earlier; and for soldiers, it may mean a better chance of receiving care before problems become chronic.
The Army's progress also has implications for force protection and training policy. If the service can better identify patterns of exposure and symptoms, it may be able to refine how units train, how often certain weapons systems are used, and what protective measures are required in high-blast environments. That could eventually influence everything from range procedures to equipment design and medical screening intervals.
Readiness And Care
The milestone should not be read as the end of the problem. Instead, it marks a point at which the Army has gathered enough participation to make the tool a meaningful part of its health architecture. The remaining task is to ensure the data is used effectively: to inform clinical decisions, guide prevention efforts and support soldiers who may be experiencing neurological effects that are easy to overlook.
For the Army, the broader strategic value is clear. A force that can detect brain-health issues earlier is better positioned to preserve combat effectiveness, reduce long-term medical burdens and improve trust among service members who rely on the institution to safeguard their health. In that sense, the 97% figure is more than a participation statistic. It is evidence that the service is trying to institutionalize a new standard of care around one of the most complex health risks facing modern troops.
As military leaders continue to confront the consequences of blast exposure, the Army's near-complete adoption of the Neurocognitive Assessment Tool may become a model for how large defense organizations translate emerging medical concerns into routine practice. The real test now is whether the screening system can consistently identify those at risk and help prevent minor exposures from becoming lasting injuries.